Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
Simon P. Kim, Paul L. Crispen, R. Houston Thompson, Christopher J. Weight, Stephen A. Boorjian, Brian A. Costello, Christine M. Lohse, Bradley C. LeibovichVolume:
118
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/cncr.26695
File:
PDF, 286 KB
english, 2012